NYSEMKT: MYOMyomo Inc Stock Ownership - Who owns Myomo?
Insider buying vs selling
Have Myomo Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Harry Kovelman | Med | 2026-09-11 | 15,488 | $1.27 | $19.69kSell |
| Milton Mayo Morris | Director | 2026-09-02 | 15,000 | $1.41 | $21.15kSell |
| Harry Kovelman | Med | 2026-08-20 | 17,250 | $1.73 | $29.89kSell |
| Harry Kovelman | Med | 2026-08-20 | 17,250 | $1.73 | $29.89kSell |
| Harry Kovelman | Med | 2026-08-20 | 17,500 | $1.73 | $30.33kSell |
| David A. Henry | CFO | 2026-08-07 | 25,310 | $1.42 | $35.94kSell |
| Micah Mitchell | CCO | 2026-08-07 | 21,559 | $1.42 | $30.61kSell |
| Harry Kovelman | Med | 2026-08-07 | 22,457 | $1.42 | $31.89kSell |
| David A. Henry | Chief Financial Officer | 2026-07-13 | 5,166 | $1.09 | $5.63kSell |
| Harry Kovelman | Chief Medical Officer | 2026-06-12 | 10,442 | $1.20 | $12.53kSell |
MYO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MYO insiders and whales buy or sell their stock.
MYO Shareholders
What type of owners hold Myomo Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Joseph M. Manko Jr. | 5.52% | 2,187,282 | $2.82M | Insider |
| Paul R. Gudonis | 3.62% | 1,434,679 | $1.85M | Insider |
| Thomas F. Kirk | 1.95% | 772,569 | $996.61k | Insider |
| Mgc Venture Partners 2013 LP | 1.71% | 678,105 | $874.76k | Insider |
| Steve Sanghi | 1.44% | 570,621 | $736.10k | Insider |
| David A. Henry | 1.19% | 470,163 | $606.51k | Insider |
| Heather C. Getz | 0.53% | 210,458 | $271.49k | Insider |
| Milton Mayo Morris | 0.53% | 208,391 | $268.82k | Insider |
| Thomas Aloysius Crowley Jr. | 0.39% | 154,931 | $199.86k | Insider |
| Micah Mitchell | 0.33% | 130,738 | $168.65k | Insider |
MYO vs Medical Device Stocks
Myomo Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.